Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells

By sjmartinez • January 10, 2025

Wu K, Ge XX, Duan XF, Li JQ, Wang K, Chen QH, Huang ZM, Zhang WY, Wu Y, Li Q. Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells. Drug Resist Updat. 2024 Dec 24;79:101196. doi: 10.1016/j.drup.2024.101196. Epub ahead of print. PMID: 39787991.

Tags: breast cancer, Dephosphorylation, FOXO3a, General Internal Medicine, King Drew Med Ctr, Post Doc, Publications, TRAIL, Wip1

Breaking the Chain of Survival: What Progetto Vita Tells Us, and What It Doesn’t

Talishinsky A, Ajijola OA, Salhi RA. Breaking the Chain of Survival: What Progetto Vita Tells Us, and What It Doesn't. J Am Heart Assoc. 2025[...]

Longitudinal Trajectories of Multimorbidity and Psychosocial Resilience Resources in Midlife and Older Adults: Findings From the Health and Retirement Study

White Whilby K, Robinson-Ector K, Bell BA, Ma T, Hasan S, Quiñones AR, Wei MY. Longitudinal Trajectories of Multimorbidity and Psychosocial Resilience Resources in Midlife[...]

Applying Race and Ethnicity in Health Disparities Research

Norris KC, Hudson MF, Wilson MR, Wojcik GL, Ofili EO, Hedges JR. Applying Race and Ethnicity in Health Disparities Research. Int J Environ Res Public[...]